← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 5,357

Funds Holding Change +353

Funds Holding Growth +7%

Value $1.22T

Holding in Top 10 668

Top 10 Change -195

Top 10 Growth -23%

Value Growth -12%

New 647

Increased 1,956

Reduced 2,475

Closed 201

Capital Inflow $54.2B

Capital Outflow $47.2B

Net Capital Flow +$7.08B

Capital Flow Change +$10.7B

Calls $22.1B

Puts $23B

Net Calls -$966M

Put/Call Ratio 1.04